Geode Capital Management’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
Other funds holding IMCR
Geode Capital Management's IMCR Position: Q3 2026 in Review
Geode Capital Management increased its Immunocore (IMCR) stake by 13% in Q3 2026, buying an estimated $199K and bringing the position to 51,840 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #3225.
Geode Capital Management first reported a position in IMCR in Q2 2021 and has held it in 22 quarters since. The position peaked at $1.78M in Q4 2023. 31 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.
- Geode Capital Management held 51,840 shares of Immunocore worth $1.57M as of Q3 2026.
- Geode Capital Management bought 5,866 Immunocore shares in Q3 2026, an estimated $199K.
- Immunocore made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3225 holding.
- Geode Capital Management first reported a position in Immunocore in Q2 2021 and has held it in 22 quarters since.
- Geode Capital Management's Immunocore position peaked at $1.78M in Q4 2023.
- 31 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.